PharmacoEconomics & Outcomes News

, Volume 589, Issue 1, pp 4–4 | Cite as

Insulin aspart looks good for T2DM in Japan

Clinical study


Time Horizon Medical Data Human Insulin European Association Insulin Aspart 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Pollock RF, Valentine WJ, THOMSEN TL, Nishimura H.Use of rapid-acting insulin aspart reduces costs and cardiovascular complications in type 2 diabetes when compared with human insulin. 45th Annual Meeting of the European Association for the Study of Diabetes: abstr. 891, 30 Sep 2009. Available from: URL:

Copyright information

© Adis International Ltd 2009

Personalised recommendations